The Global Feed Anticoccidials Market is accounted for $312.56 million in 2018 and is expected to reach $523.60 million by 2027 growing at a CAGR of 5.9% during the forecast period. High threat of coccidiosis in livestock and strong demand for anticoccidials are some of the factors fuelling the market growth. However, stringent regulations, ban on anticoccidials and potent residue levels of medicated feed ingredients are restricting market growth.

Feed infections are of extraordinary issue in the poultry business because of its effect on the profitability of the poultry, just as increment in the mortality, attributable to enteric maladies. Avian Coccidiosis is an enteric ailment brought about by the protozoan. Coccidiosis is one of the most widely recognized infections found in poultry over the world. It is viewed as the monetarily most significant ailment of poultry. The infection spreads through the defiled water or nourishment. As the brooding time of the coccidiosis is just eight days, it attacks the feathered creature or creature rapidly.

Based on livestock, the poultry segment is estimated to have a lucrative growth due to the demand of feed anticoccidials is high, where it can be used as a control measure for the complete prevention of infestation of coccidia (severe disease in poultry). By Geography, Asia Pacific is likely to have a huge demand due to the lenient regulations on the usage of anti coccidial in feed and increasing livestock population in the region.

Some of the key players profiled in the Feed Anticoccidials market include Bioproperties Pty. Ltd., Ceva Animal Health, Elanco Animal Health, Huvepharma, Impextraco, Kemin Industries, Merck Animal Health, Phibro Animal Health, Qilu Animal Health Products Co. Ltd., Virbac SA, Zoetis and Zydus Animal Health.

Forms Covered:

  • Dry
  • Liquid



Sources Covered:

  • Chemical
  • Natural



Drug Types Covered:

  • Antibiotic Anticoccidials
  • Chemical Derivative Anticoccidials
  • Ionophore Anticoccidials



Mode of Consumptions Covered:

  • Injection
  • Oral



Types Covered:

  • Diclazuril
  • Dinitro-O-Toluamide (DOT)
  • Lasalocid
  • Monensin
  • Narasin
  • Nicarbazin
  • Salinomycin
  • Other Types



Livestocks Covered:

  • Cattle
  • Companion Animal
  • Fish
  • Poultry
  • Ruminants
  • Swine
  • Others Livestocks



Regions Covered:

  • North America
  • ·US
  • ·Canada
  • ·Mexico
  • Europe
  • ·Germany
  • ·UK
  • ·Italy
  • ·France
  • ·Spain
  • ·Rest of Europe
  • Asia Pacific
  • ·Japan
  • ·China
  • ·India
  • ·Australia
  • ·New Zealand
  • ·South Korea
  • ·Rest of Asia Pacific
  • South America
  • ·Argentina
  • ·Brazil
  • ·Chile
  • ·Rest of South America
  • Middle East & Africa
  • ·Saudi Arabia
  • ·UAE
  • ·Qatar
  • ·South Africa
  • ·Rest of Middle East & Africa



What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub-segments, and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements



Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
  • ·Comprehensive profiling of additional market players (up to 3)
  • ·SWOT Analysis of key players (up to 3)
  • Regional Segmentation
  • ·Market estimations, Forecasts and CAGR of any prominent country as per the client’s interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
  • ·Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances